These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16245429)

  • 1. [The efficacy and safety of trazodone in the treatment of adjustment disorders--naturalistic research].
    Gałecki P; Zboralski K; Florkowski A
    Pol Merkur Lekarski; 2005 Aug; 19(110):183-7. PubMed ID: 16245429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trazodone--its multifunctional mechanism of action and clinical use].
    Frecska E
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):477-82. PubMed ID: 21220793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study.
    Razavi D; Kormoss N; Collard A; Farvacques C; Delvaux N
    J Int Med Res; 1999; 27(6):264-72. PubMed ID: 10726235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study.
    De Wit S; Cremers L; Hirsch D; Zulian C; Clumeck N; Kormoss N
    J Int Med Res; 1999; 27(5):223-32. PubMed ID: 10689628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study.
    Camargos EF; Louzada LL; Quintas JL; Naves JO; Louzada FM; Nóbrega OT
    Am J Geriatr Psychiatry; 2014 Dec; 22(12):1565-74. PubMed ID: 24495406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of trazodone retard monotherapy: results of the Serbian non-interventional study.
    Miljevic CD; Lečić-Toševski D; Trazodone Study Group Serbia
    Int J Psychiatry Clin Pract; 2016 Sep; 20(3):133-40. PubMed ID: 27335239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trazodone and venlafaxine in treatment of depressive disorders].
    Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
    Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study.
    Calandre EP; Morillas-Arques P; Molina-Barea R; Rodriguez-Lopez CM; Rico-Villademoros F
    BMC Musculoskelet Disord; 2011 May; 12():95. PubMed ID: 21575194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder.
    Kasper S; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2005 Aug; 21(8):1139-46. PubMed ID: 16083521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-a-Day Trazodone in the Treatment of Depression in Routine Clinical Practice.
    Češková E; Šedová M; Kellnerová R; Starobová O
    Pharmacology; 2018; 102(3-4):206-212. PubMed ID: 30099450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
    Shamseddeen W; Clarke G; Keller MB; Wagner KD; Birmaher B; Emslie GJ; Ryan N; Asarnow JR; Porta G; Brent DA
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):29-36. PubMed ID: 22251024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the evidence for the efficacy and safety of trazodone in insomnia.
    Mendelson WB
    J Clin Psychiatry; 2005 Apr; 66(4):469-76. PubMed ID: 15816789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Cui X; Calabrese JR; Gao K;
    J Clin Psychopharmacol; 2011 Oct; 31(5):638-42. PubMed ID: 21869688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of trazodone on sleep in patients treated with stimulant antidepressants.
    Kaynak H; Kaynak D; Gözükirmizi E; Guilleminault C
    Sleep Med; 2004 Jan; 5(1):15-20. PubMed ID: 14725822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study.
    Stryjer R; Spivak B; Strous RD; Shiloh R; Harary E; Polak L; Birgen M; Kotler M; Weizman A
    Clin Neuropharmacol; 2009; 32(2):82-4. PubMed ID: 18978492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.